Abstract:AbstractThe transcription factor NRF2 (NFE2L2) is a pivotal activator of genes encoding cytoprotective and detoxifying enzymes that limit the action of cytotoxic therapies in cancer. NRF2 acts by binding antioxidant response elements (ARE) in its target genes, but there is relatively limited knowledge about how it is negatively controlled. Here, we report that retinoic X receptor alpha (RXRα) is a hitherto unrecognized repressor of NRF2. RNAi-mediated knockdown of RXRα increased basal ARE-driven gene expression and induction of ARE-driven genes by the NRF2 activator tert-butylhydroquinone (tBHQ). Conversely, overexpression of RXRα decreased ARE-driven gene expression. Biochemical investigations showed that RXRα interacts physically with NRF2 in cancer cells and in murine small intestine and liver tissues. Furthermore, RXRα bound to ARE sequences in the promoters of NRF2-regulated genes. RXRα loading onto AREs was concomitant with the presence of NRF2, supporting the hypothesis that a direct interaction between the two proteins on gene promoters accounts for the antagonism of ARE-driven gene expression. Mutation analyses revealed that interaction between the two transcription factors involves the DNA-binding domain of RXRα and a region comprising amino acids 209-316 in human NRF2 that had not been defined functionally, but that we now designate as the NRF2-ECH homology (Neh) 7 domain. In non–small cell lung cancer cells where NRF2 levels are elevated, RXRα expression downregulated NRF2 and sensitized cells to the cytotoxic effects of therapeutic drugs. In summary, our findings show that RXRα diminishes cytoprotection by NRF2 by binding directly to the newly defined Neh7 domain in NRF2. Cancer Res; 73(10); 3097–108. ©2013 AACR.

Retinoid X receptor signaling pathway in leukemia

The Pathophysiological Roles and Regulatory Mechanism of Retinoic Acid Receptor-related Orphan Receptors

The Function of Retinoid X Receptor Α in Cancer Cells

Regulation of the Nongenomic Actions of Retinoid X Receptor-Α by Targeting the Coregulator-Binding Sites

RXR Signaling Targeted Cancer Therapy

Targeting Truncated RXRα for Cancer Therapy.

RXRα Inhibits the NRF2-ARE Signaling Pathway Through a Direct Interaction with the Neh7 Domain of NRF2.

Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy

Retinoid X Receptor Heterodimers in Hepatic Function: Structural Insights and Therapeutic Potential

Retinoid X Receptor Regulates Nur77/Thyroid Hormone Receptor 3-Dependent Apoptosis by Modulating Its Nuclear Export and Mitochondrial Targeting

Retinoic Acid Receptor-Related Orphan Receptors: Critical Roles in Tumorigenesis

The multi-faceted role of retinoid X receptor in cardiovascular diseases

Retinoid X Receptor Regulates Nur77/TR3-Dependent Apoptosis by Modulating Its Nuclear Export and Mitochondrial Targeting

Comparison of phenotypic and global gene expression changes in Xenopus tropicalis embryos induced by agonists of RAR and RXR.

Molecular mechanism of liver X receptors in cancer therapeutics

The multi-faceted role of retinoid X receptor in bone remodeling

Function Annotation of Hepatic Retinoid X Receptor Α Based on Genome-Wide DNA Binding and Transcriptome Profiling.

Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor

Retinoic acid signaling in development and differentiation commitment and its regulatory topology

The regulation of cytokine signaling by retinal determination gene network pathway in cancer

Regulation Of Rar Beta Expression By Rar- And Rxr-Selective Retinoids In Human Lung Cancer Cell Lines: Effect On Growth Inhibition And Apoptosis Induction